Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients

被引:0
作者
Nayoung Han
Hwi-yeol Yun
Jin-yi Hong
In-Wha Kim
Eunhee Ji
Su Hyun Hong
Yon Su Kim
Jongwon Ha
Wan Gyoon Shin
Jung Mi Oh
机构
[1] Seoul National University,College of Pharmacy and Research Institute of Pharmaceutical Sciences
[2] Choongwae Pharma Corporation,Drug Discovery Laboratory
[3] Seoul National University College of Medicine,Department of International Medicine
[4] Seoul National University College of Medicine,Department of Surgery
来源
European Journal of Clinical Pharmacology | 2013年 / 69卷
关键词
Tacrolimus; Population pharmacokinetics; Pharmacogenetics; Kidney transplantation; Nonlinear mixed-effect modeling (NONMEM);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:53 / 63
页数:10
相关论文
共 287 条
[1]  
Jusko WJ(1995)Pharmacokinetics of tacrolimus in liver transplant patients Clin Pharmacol Ther 57 281-290
[2]  
Piekoszewski W(1995)Clinical pharmacokinetics of tacrolimus Clin Pharmacokinet 29 404-430
[3]  
Klintmalm GB(1996)Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation Transplantation 62 920-926
[4]  
Shaefer MS(2003)Tacrolimus - A further update of its use in the management of organ transplantation Drugs 63 1247-1297
[5]  
Hebert MF(2004)Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation Clin Pharmacokinet 43 623-653
[6]  
Piergies AA(2005)The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression? Pharmacogenomics 6 323-337
[7]  
Lee CC(2002)Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA Drug Metab Dispos 30 1108-1114
[8]  
Schechter P(2003)Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients Pharmacogenetics 13 89-95
[9]  
Mekki QA(2001)The genetic determinants of the CYP3A5 polymorphism Pharmacogenetics 11 773-779
[10]  
Venkataramanan R(2002)Genetic contribution to variable human CYP3A-mediated metabolism Adv Drug Deliv Rev 54 1271-1294